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Abstract
Background: Despite high levels of prenatal alcohol exposure in the UK, evidence 
on the prevalence of fetal alcohol spectrum disorders (FASD) is lacking. This paper 
reports on FASD prevalence in a small sample of children in primary school.
Methods: A 2- phase active case ascertainment study was conducted in 3 main-
stream primary schools in Greater Manchester, UK. Schools were located in areas 
that ranged from relatively deprived to relatively affluent. Initial screening of children 
aged 8– 9 years used prespecified criteria for elevated FASD risk (small for age; special 
educational needs; currently/previously in care; significant social/emotional/mental 
health symptoms). Screen- positive children were invited for detailed ascertainment of 
FASD using gold standard measures that included medical history, facial dysmorphol-
ogy, neurological impairment, executive function, and behavioral difficulties.
Results: Of 220 eligible children, 50 (23%) screened positive and 12% (26/220) pro-
ceeded to Phase 2 assessment. Twenty had a developmental disorder, of whom 4 had 
FASD and 4 were assessed as possible FASD. The crude prevalence rate of FASD in 
these schools was 1.8% (95% CI: 1.0%, 3.4%) and when including possible cases was 
3.6% (2.1%, 6.3%). None of these children had previously been identified with a de-
velopmental diagnosis.
Conclusions: FASD was found to be common in these schools and most of these chil-
dren's needs had not previously been identified. A larger, more definitive study that 
uses a random sampling technique stratified by deprivation level to select schools is 
needed to make inferences regarding the population prevalence of FASD.
K E Y W O R D S
attention- deficit hyperactivity disorder, autism spectrum disorder, fetal alcohol spectrum 
disorder, fetal alcohol syndrome, neurodevelopmental disorder
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INTRODUC TION
An estimated 10% of pregnancies globally are exposed to alcohol, a 
potent teratogen that can lead to physical and neurodevelopmental 
birth defects (Popova et al., 2017), collectively known as fetal alcohol 
spectrum disorders (FASD) (Cook et al., 2016). FASD is an umbrella 
term that includes the diagnoses of fetal alcohol syndrome (FAS), 
pFAS (partial fetal alcohol syndrome), ARBD (alcohol- related birth 
defects), and ARND (alcohol- related neurodevelopmental disorder)/
ND- PAE (Neurobehavioral Disorder Associated with Prenatal Alcohol 
Exposure).
The prevalence of FASD is estimated to be 0.8% globally and 
highest in Europe, at 2% (Lange et al., 2017). There are no direct esti-
mates of prevalence in the 4 countries with the highest known rates 
of prenatal alcohol exposure (Ireland, Belarus, Denmark and UK), 
all of which have rates of over 40% pregnancies exposed to alcohol 
(Popova et al., 2017). For the UK, the modeled estimate suggests 
3.2% of children and young people may have FASD (Lange et al., 
2017). A national study in the United States, on populations rela-
tively similar to those in the UK, found a weighted estimate of 3– 10% 
for FASD in children in primary school (May et al., 2018). Where a UK 
cohort with high levels of exposure (79% of mothers drank during 
the pregnancy, with 25% at binge levels) was used, 6– 17% of chil-
dren screened positive for features of FASD (McQuire et al., 2019). 
However, the lack of direct evidence of prevalence contributes to 
underinvestment in diagnostic, treatment, and prevention services 
(Scholin et al., 2021).
Active case ascertainment studies, the basis of global and na-
tional prevalence estimates (Lange et al., 2017; May et al., 2018), are 
considered the “gold standard” method of estimating prevalence and 
involve screening a cross section of the general population of chil-
dren (Roozen et al., 2016). Passive methods are less useful because 
individuals with FASD are often not diagnosed (May & Gossage, 
2001; Morleo et al., 2011) for a number of reasons, including a lack 
of knowledge/training among healthcare/educational professionals 
(Mukherjee et al., 2015); and difficulty in differentiating features of 
FASD from other commonly co- occurring disorders (e.g., attention- 
deficit/hyperactivity disorder, ADHD, or autism spectrum disorder, 
ASD) (Chasnoff, Wells & King, 2015; Mukherjee et al., 2011; Young 
et al., 2016).
The aim of this study was to provide direct evidence of the prev-
alence of FASD in a small sample of UK children aged 8 to 9 years.
MATERIAL S AND METHODS
Setting
The setting was Greater Manchester, North West England (popula-
tion 2.8 million), an area with a higher than England average level 
of alcohol harm (Public Health England, 2021), and relatively high 
deprivation (Ministry of Housing Communities & Local Government, 
2019).
This study was part of a wider initiative, the “Preventing 
Alcohol Exposed Pregnancy Programme,” taking place in 4 of the 
10 Greater Manchester local authority areas. The initiative also in-
cluded increased awareness raising and interventions with women 
who were pregnant or at risk of unplanned pregnancy (Reynolds 
et al., 2021).
Design
We report on a cross- sectional study to detect cognitive impair-
ments and associated conditions, including FASD, using an ac-
tive case ascertainment method. Based on the World Health 
Organization (WHO) standard protocol for FASD prevalence stud-
ies (World Health Organisation, 2012), children in school year 3/4 
(8– 9 years of age at enrollment) who were able to communicate in 
English were invited to take part in a 2- phase approach. Children 
with a known risk factor for FASD went to the second phase (full 
assessment, see section below, Phase 1: initial screening, Figure 1). 
Child assessments took place between July 2019 and March 2020. 
Restrictions related to the COVID- 19 pandemic prevented face- to- 
face data collection from mid- March 2020, at which point there 
was one outstanding parent interview, which was conducted by 
telephone in March 2020.
Sample size
A sample size of 170 was adequate to get a preliminary indication 
of prevalence in a selected sample of schools (based on estimated 
true prevalence = 0.03, precision = 0.05; sensitivity = 0.85; specific-
ity = 0.85). We aimed to recruit 3 schools (assuming approximately 
60 pupils in the relevant age category per school).
School recruitment
In this pragmatic, small- scale study, schools were purposefully se-
lected. Key informants (e.g., local government officials who work 
with schools, education psychologists) were consulted and sug-
gested 4 schools, all of which agreed to take part. One school was 
excluded due to disengagement from the study and deviation from 
the protocol (see Appendix S1 for details of a partial data set). We in-
itially aimed to include a specialist school providing Social Emotional 
and Mental Health (SEMH) support. All such schools within the 
study area were contacted; one agreed to take part but withdrew 
after being unable to gain consent from any parents.
In February 2020, an extension of data collection was granted 
with the aim to recruit further schools to increase the baseline 
sample size. Four additional schools were recruited. However, the 
imposition of COVID- 19– related restrictions, including lockdown, 
meant that the study could not be completed in the second wave of 
schools. Partial results are reported in Appendix S1.
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F I G U R E  1  Study design
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Phase 1: Initial Screening
Parents of all eligible children were sent a letter describing the 
study, with the option to opt- out, at least 5 days before data col-
lection. Parents who wished to remove their child from the study 
at this stage were advised to return the letter with the opt- out op-
tion selected. Researchers were present in school to assess physical 
measurements. Height was measured using a mobile stadiometer, 
weight using Marsden MBF- 6000 scales, and head circumference 
(OFC) using a Sec 201 measuring tape. To become eligible for Phase 
2 (full assessment), one or more of the following criteria had to be 
met: height or weight below the ninth centile or OFC below the 
second centile; identified by the school or parents as having dif-
ficulties with learning, maladaptive behavior, and inattention or 
hyperactivity issues; have an Education, Health and Care Plan; 
be a currently or previously looked- after child; and already have 
diagnosed difficulties with behavior including ADHD or conduct 
disorder. Exclusion criteria were as follows: disabilities or behav-
ioral abnormalities known to be caused by well- characterized and 
already- identified genetic factors (e.g., Down syndrome, Williams 
syndrome) or by postnatal brain injuries. These were excluded be-
cause the physical/behavioral stigmata overlap with FASD in pres-
entation, and an FASD label cannot be attributed as the primary 
etiological factor.
Phase 2a: Measures completed by parents/carers
Parents of those meeting criteria for Phase 2 were sent information 
sheets and consent forms to opt themselves and their child into the 
study either by email, by letter sent home, by telephone, or in per-
son by the special educational needs coordinator or head teacher. 
Where children were currently under the care of the local author-
ity, consent was obtained from the supervising social worker. For 
parent- report assessments, most took place at school in a private 
room for 2- hour sessions. Where requested by the parent, assess-
ments took place in their home.
Parent- report assessments used the validated measures listed 
in Figure 1. The medical history was taken using a structured ques-
tionnaire developed originally at the University of New Mexico 
(May et al., 2018). The schedule included questions on prepreg-
nancy, pregnancy and current substance use (alcohol, tobacco, 
prescription, and illicit drugs), folic acid use in pregnancy, and birth 
complications. General questions on current alcohol consumption 
were asked first as part of wider lifestyle set of questions, fol-
lowed by questions about alcohol consumption in pregnancy. If 
alcohol was consumed during pregnancy, further questions ascer-
tained the level and timing of consumption. Birth mothers were 
interviewed privately in order to encourage open reporting of 
alcohol use. For looked- after children, and fostered or adopted 
children, the parent/carer with most knowledge of the child was 
interviewed.
Phase 2b: Measurements on children
Measurements took place in school during school hours. 
Dysmorphology of fetal alcohol syndrome (FAS) facial charac-
teristics was assessed from photographs (using standardized 
alignment of the participant's head relative to the camera lens) 
taken by trained researchers. Images were analyzed by FAS Facial 
Photographic Analysis Software (Astley, 2015) and validated by an 
experienced clinical geneticist. Neurological impairment was as-
sessed using the Developmental NEuroPSYchological Assessment 
(NEPSY) to assess memory, attention, and executive functions. 
The NEPSY subtests (Inhibition, Narrative Memory and Word 
List Interference, Animal Sorting, Clocks, and Memory for Faces) 
were those that had been identified in previous FASD research 
(Rasmussen et al., 2013). The Wechsler Intelligence Scale for 
Children (WISC- V) (Kaufman et al., 2015) was used to assess the 
child's cognition, as used in previous FASD studies (Raldiris et al., 
2018).
Phase 2c: Ruling out genetic causes and 
case conference
The results of the assessments were compared with the case defini-
tion (Table 1), derived from the WHO protocol for prevalence stud-
ies (World Health Organisation, 2012) and international guidelines 
(Cook et al., 2016). Where deficits met criteria in 3 subdomains, 
and PAE was present, FASD was considered. Where a child had 
all 3 sentinel facial features associated with FAS, FASD was con-
sidered in the absence of reported PAE. For all those considered 
for FASD, a microarray comparative genomic hybridization (array 
CGH) test was used to rule out other disorders that may present 
with a similar behavioral presentation of genetic origin (Douzgou 
et al., 2012). A saliva sample was taken using the Oragene DNA OG- 
575 (DNA Genotek, 2020). The Oligo (Oxford Gene Technology, 
Oxford, UK) Hx60k array was carried out by the North Western 
Regional Genetics Laboratory within Manchester University NHS 
Foundation Trust, Manchester.
Findings for each child were discussed during case conferences 
attended by the study team including clinicians with expertise in the 
diagnosis of FASD. Cases of FASD were defined according to inter-
nationally recognized guidelines (Cook et al., 2016). Possible cases 
were where FASD was suspected but information was missing or 
unclear, for example regarding alcohol use.
Data analysis
Prevalence was estimated as the total number of children with FASD 
and probable FASD as the numerator, and the total number of eli-
gible children at the same site as the denominator. This generates a 
conservative or minimum estimate of prevalence as it assumed that 
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all children who were not examined did not have FASD. To obtain 
confidence intervals, we accounted for clusters (schools) by using 
nonparametric bootstrapping, resampling with replacement clusters 
with 10,000 bootstrap runs.
Ethical considerations
Parents were invited to take part and were offered a report on their 
child's learning and behavioral issues, which could include a range of 
learning difficulties, including possible ASD, ADHD, and FASD. The 
text of the information sheet made it clear that the main objective 
was to ascertain FASD prevalence.
A small number of participants took part in genetic testing, 
which can occasionally identify markers for other health condi-
tions. The information sheet sought to ensure that the parents/car-
ers understood possible outcomes of the genetic test before giving 
consent.
Ethical approval was granted by the University of Salford Ethics 
committee in May 2019 (reference: HSR1819- 100).
RESULTS
Participating schools
Schools represented a range of deprivation when measured by 
the index of multiple deprivation. School 1 was located in one of 
England's 20% most deprived areas, and school 3, 30%. School 2 was 
located among the 20% most affluent areas in England.
Flow of participants
A total of 220 children were invited and 203 children took part in 
the Phase 1 physical measures (height, weight, and OFC) (Figure 2). 
Fifty children were eligible for full assessment (Phase 2) because of 
screening positive on the physical measures, parent/teacher con-
cerns, already acknowledged as SEN, or currently or previously 
being in local authority care (Table 2).
Assessment was not possible on 24 children due largely to par-
ents not giving consent or being uncontactable.
TA B L E  1  Measures used and fetal alcohol spectrum disorder (FASD) domains of impairment
Domain Subdomain Measure
Growth Height below 9th percentile and weight below 9th percentile, 
medical history
Face Photographic measurements using 4- digit FAS Facial 
Measurement software
Central Nervous System Brain OFC below 2nd centile, medical history, or brain scan report
Hard/ soft neurological signs SSP defined differences in 2 or more domains
History of formally diagnosed motor disorder, for example, 
dyspraxia
History of epilepsy or other neurological issues (from medical 
history)
Communication CCC−2, Vineland communication domain. Defined by 
abnormality >1.5 standard deviations below the mean
Cognition WISC- V: Full- Scale IQ 2 standard deviations from norm or 
2 standard deviations between different subdomains
Executive function BRIEF overall score: score above clinical cutoff range
NEPSY executive function domain Score 1.5 standard 
deviations from norm or 2 standard deviations between 
subdomains
Memory WISC- V, NEPSY memory domain
Attention SDQ attention domain scores above clinical cutoffs
NEPSY attention domain
Adaptive behavior, social skills SCQ (score above 15), SDQ (score above clinical cutoff), 
Vineland social domain, Vineland daily living skills domain 
(both scores 1.5 standard deviations from mean)
Academic Teacher report, below average level, has EHC Plan
Alcohol consumption of birth mother History information sheet
Abbreviations: BRIEF, Behaviour Rating Inventory of Executive Function; CCC- 2, Communication Checklist for Children; EHC Plan, Education, Health 
and Care Plan; FAS, fetal alcohol syndrome. IQ, Intelligence Quota; NEPSY, NEuroPSYchological Assessment; OFC, occipital frontal circumference; 
SSP, short sensory profile; SCQ, Social Communication Questionnaire; SDQ, Strengths and Difficulties Questionnaire; WISC- V, Wechsler Intelligence 
Scale for Children, Fifth UK Edition.
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Full assessment took place with 26 children, four of whom 
had FASD and a further four were identified as possible FASD 
(Table 2). Other developmental disorders identified are detailed 
in Appendix S2.
Of the children with full data sets, none had reported exposure 
to known teratogenic antiepileptic pharmaceuticals. Two had expo-
sure to illegal drugs, and over two thirds of the children assessed 
(68%) has some prenatal exposure to alcohol (Table 3).
Of the FASD cases, none had a prior clinical diagnosis of any neu-
rodevelopmental disorder or an Education, Health and Care (EHC) 
Plan, and only one child had been identified by the school as hav-
ing special educational needs. Three of the four cases had high- risk 
prenatal alcohol exposure reported, while in the fourth, alcohol was 
not reported but the child had severe FAS facial features, small for 
age, a low full- scale IQ of 66, and a normal CGH array (a summary of 
cases and possible cases assessed against the FASD criteria is given 
in Appendix S2).
Of the possible cases where FASD was suspected but not 
confirmed, none had a clinical diagnosis of any neurodevelop-
mental disorder and only one had an EHC Plan. All were on the 
schools’ special educational needs register, had prenatal expo-
sure to alcohol, and had deficits in at least three subdomains. 
Of the 12 children with a suspected disorder that was deemed 
unlikely to be FASD, 11 had some level of prenatal exposure to 
alcohol (Table 3).
Prevalence rates
We calculated a conservative (minimum) prevalence of FASD of 
1.8% 4/220 (95% CI [1.0, 3.4]) and a conservative (minimum) preva-
lence that also included possible FASD of 3.6% 8/220 (95% CI [2.1, 
6.3]) within our study population.
DISCUSSION
Prevalence of FASD
This is the first FASD active case ascertainment study to be carried out 
in the UK, a country with one of the highest rates of drinking in preg-
nancy in the world. These prevalence estimates, though not necessarily 
generalizable to other communities, are in line with a modeled popula-
tion prevalence estimate for the UK of 3.2% (Lange et al., 2017) and 
consistent with a screening prevalence of 6– 17% in a secondary analy-
sis of data from a cohort study of children born in the 1990s (McQuire 
et al., 2019). As per May et al. (2018), our prevalence estimates could be 
considered as “conservative” because we assumed all those who we did 
not fully assess did not have FASD. Further work examining the preva-
lence of FASD taking account of maternal sociodemographic factors 
and trends in alcohol consumption would allow a more precise estimate 
of the likely burden of this condition in the UK.
F I G U R E  2  Flow of participants through the study. SFA, small for age; SEN, on school educational needs register; LAC, "looked- after 
child," that is, in the care of the local authority; PrevLAC, previously looked- after child, that is, adopted
    | 7UK FETAL ALCOHOL SPECTRUM DISORDER PREVALENCE
TA B L E  2  Screening and assessment data by school
School 1 (baseline 
N = 44) School 2 (baseline N = 118)
School 3 (baseline 
N = 59) Total (N = 220)
Screened at stage 1, n (% of 
baseline)
38 (86) 109 (92) 56 (95) 203 (92)
Sex, n (% of baseline)
Male 18 (40) 55 (46) 30 (51) 103 (47)
Female 20 (45) 54 (46) 26 (44) 100 (45)
Age, Years (y) and months (m)
Median 8y11m 8y10m 8y6m 8y10m
[interquartile range] [8y9m, 9y5m] [8y5m, 9y6m] [8y3m, 8y11m] [8y 5m, 9y4m]
(range) (8y3m, 9y9m) (8y0m, 9y10m) (8y0m, 9y8y) (8y0m, 9y10m)
Physical screen positive, n (% of baseline)
Height <9th percentile 4 (9) 7 (6) 2 (3) 13 (6)
Weight <9th percentile 2 (5) 3 (3) 2 (3) 7 (3)
OFC <2th percentile 1 (2) 1 (1) 1 (2) 3 (1)
Reason for recruitment, n (% of invited)
SEN 14 (66) 7 (43) 5 (50) 26 (13)
SFA 3 (14) 5 (31) 4 (40) 12 (6)
LAC 2 (10) 3 (18) 1 (10) 6 (3)
SFA + SEN 2 (10) 0 0 2 (1)
SFA + prevLAC 0 1 (6) 0 1 (0.5)
Parent opt- in 0 3 (16) 0 3 (1)
Invited to second phase 21 19 10 50
Phase 2 assessments N = 10 N = 9 N = 7 N = 26
Referral reason, n (% of Phase 2 participants)
SEN 5 (50) 3 (33) 4 (57) 12 (46)
SFA 3 (30) 0 2 (29) 5 (19)
LAC 0 2 (22) 1 (14) 3 (12)
SFA and SEN 2 (20) 0 0 2 (8)
SFA and PrevLAC 0 1 (11) 0 1 (4)
parent opt- in 0 3 (33) 0 3 (11)
Maternal ethnicity, n (%)
White UK 10 (100) 8 (89) 6 (86) 24 (92)
Nonwhite 0 1 (11) 0 1 (4)
Not reported 0 0 1 (14) 1 (4)
Maternal educational qualifications, highest received, n (%)
<4 GCSEs 2 (20) 0 1 (14) 3 (12)
4+GCSEs 4 (40) 0 2 (29) 6 (23)
2+A levels 2 (20) 3 (33) 1 (14) 6 (23)
Degree 2 (20) 4 (44) 2 (29) 8 (30)
Missing data 0 2 (22) 1 (14) 3 (12)
Full assessment
Deficits in 3 subdomains met, n 
(% of assessed)
8 (80) 7 (78) 6 (86) 21 (80)
FASD, n (% of assessed)
FASD 1 (10) 3 (33) 0 (0) 4 (15)
FASD and possible FASD 3 (30) 4 (44) 1 (10) 8 (30)
(Continues)
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The study region (Greater Manchester) sees approximately 
34,000 babies born per year (ONS, 2020), yet diagnoses only around 
36 cases of FASD per year (unpublished data from a Freedom of 
Information request). This low rate of diagnosis in relation to the ex-
ample local prevalence we have demonstrated here suggests that 
increased recognition and diagnostic capacity is required. This is im-
portant because early diagnosis and support for families affected by 
FASD can prevent or mitigate adverse secondary outcomes, such 
as school exclusions, poor job prospects, and mental ill health (Alex 
& Feldmann, 2012; Landgren, et al., 2019; Rangmar et al., 2015; 
Streissguth, et al., 2004).
Strengths and limitations
We demonstrated successful engagement with the three schools 
who made intensive efforts on our behalf to recruit parents. The 
schools covered a range of communities in different levels of depri-
vation, with two serving relatively deprived populations and one rel-
atively affluent. A larger, more definitive study would use a random 
sampling technique, stratified by deprivation level, to select schools.
We were unable to obtain sufficient information for almost half 
(24/50) of the children who were identified as being at higher risk 
of FASD (i.e., those who were identified in Phase 1 screening). A 
further 9 were actively withdrawn before Phase 1 screening, and 
selection took place. It is not possible to know whether the propor-
tion of cases would have been higher or lower in these groups that 
did not take part. It is also possible that there were cases of FASD in 
the remaining 161 children with no apparent risk factors. It is pos-
sible the shame and stigma associated with FASD or developmental 
disorders in general impacted on participation. Low participation 
has been a documented issue for other prevalence studies (Caccanti 
et al., 2014; May et al., 2011; Okuliez- Kozaryn, et al., 2017) in the 
European region.
Extensive effort was made to contact each parent, and for those 
not taking part, the reasons were documented (see reasons given 
in Figure 2). The opportunity to have children's needs assessed was 
the major incentive for schools to take part in the study. For children 
in the care of foster parents, consent was required from the local 
authority, and this was particularly difficult to obtain.
We had initially hoped to include a further four schools in the 
prevalence calculations; however, disruptions due to COVID- 19 
Phase 2 assessments N = 10 N = 9 N = 7 N = 26
Other outcomes
ASD 0 (0) 2 (22) 3 (43) 5 (19)
ADHD 2 (20) 0 (0) 1 (14) 3 (12)
DLD 2 (20) 1 (11) 0 (0) 3 (12)
General learning disability 0 (0) 0 (0) 2 (28) 2 (8)
No disorder 3 (30) 2 (22
)
0 (0) 5 (19)
FASD prevalence per 100 [95% CI]
FASD 2.3 [0.3,14.8] 2.5 [0.8, 7.4] No observations 1.8 [1.0,3.4]
FASD and possible FASD 7.0 [2.2,19.8] 3.4 [1.3, 8.7] 1.7 [0.2,11.1] 3.6 [2.1,6.3]
Abbreviations: A level, Advanced Level, qualification usually taken at age 18 years; ADHD, attention- deficit/hyperactivity disorder; ASD, autism 
spectrum disorder; CI, confidence interval; DLD, developmental language disorder; FASD, fetal alcohol spectrum disorder; GCSE, General Certificate 
of Education, qualification usually taken at age 16 years; LAC, “looked- after child,” that is, under care of local authority; OFC, occipital frontal 
circumference; PrevLAC, previously looked- after child, that is, adopted; SEN, on school educational needs register; SFA, small for age.
TA B L E  2  (Continued)










Anticonvulsants 0 0 0 0
Illegal drugs 1 (25%) 0 1 (6%) 2 (8%)
Alcohol
Significant riska 3 (75%) 3 (75%) 4 (22%) 10 (38%)
Low riskb 0 1 (25%) 7 (40%) 8 (30%)
No alcohol reported 1 (25%) 0 7 (40%) 8 (30%)
aCutoff for significant risk defined as 4 or more alcoholic drinks on 4 or more occasions or >7 units a week throughout the term of the pregnancy.
bLow risk: alcohol consumed, but not meeting threshold above (Kelly, et al., 2009; Sayal et al., 2014).
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prevented completion in these schools. Partial findings are pre-
sented in Appendix S1.
We were not successful in collecting data in a Social Emotional and 
Mental Health (SEMH) school despite recruiting an enthusiastic head 
teacher at one such school. Anecdotally, parents felt they had noth-
ing to gain by taking part as their child was already benefiting from 
specialist support. Similarly, pupil referral units were not included in 
this study. Together with SEMH schools, this is another setting where 
FASD prevalence is anticipated to be higher than the mainstream 
school setting.
It is likely that prenatal alcohol exposure was underestimated 
in this study, as dose and duration of alcohol consumption during 
pregnancy was calculated from retrospective self- reporting, relying 
on recall of behaviors taking place up to 10 years prior. Social de-
sirability bias also affects reporting of alcohol consumption during 
pregnancy (Caccanti et al.,. 2014; Smith et al., 2014), and we do not 
know how much the potential for perceived shame associated with 
alcohol consumption in pregnancy may have affected reporting.
It may be beneficial for future research to consider how methods 
could be adjusted for European populations to optimize participation 
and accuracy of report of alcohol consumption in these populations.
Other general limitation in studies that measure the prevalence 
of FASD is that while there are a wide range of physical and neuro-
logical features associated with FASD, which when taken together 
increase the likelihood of FASD, the only features that are widely 
accepted as discriminating in the absence of confirmed alcohol 
exposure are the distinctive facial features. However, significant 
facial features are thought to only occur in a minority of cases of 
FASD, and likewise, in this study only 2 of the 8 cases and possible 
cases showed these distinctive features. Previous prevalence stud-
ies have used a higher threshold for the physical measurements at 
Phase 1 (e.g., a threshold of 10th percentile for OFC: May et al., 
2011), which would have made the screening stage more sensitive 
and may have led to more cases being identified. Instead, we used 
the Canadian diagnostic approach, where the detailed evaluation 
stage was more focused toward the neurocognitive deficits. We 
ruled out obvious genetic causes through chromosome microarray 
analysis and clinical geneticist review. While this helped to improve 
confidence about the etiological basis of the presentation, it is not 
possible to prove that the alcohol exposure caused the deficits. The 
converse is also true: It is not possible to rule out alcohol as an im-
portant causal factor. Every effort was taken to reduce bias that 
may give rise to false positives. The case definition used validated 
developmental assessments and was described in advance in the 
study protocol and followed internationally recognized guidance 
(Cook et al., 2016).
An improvement in our methodology would have been to include 
a random sample of children for full assessment. This would have en-
abled us to obtain characteristics of the birth mothers in a group of 
children without any risk factors for FASD (i.e., those who did not meet 
the Phase 1 screening criteria), which would have allowed more sophis-
ticated modeling (and extrapolation) of the likely prevalence in the en-
tire population of 8- to 9- year- olds (May et al., 2018). In this small- scale 
study, we determined that this would have been difficult. Parents were 
prepared to take part if they thought it might benefit their child, for 
example, by getting more information to inform their special educa-
tional needs or to obtain a diagnosis. The fact that our assessment also 
identified possible ASD, ADHD, and other neurodevelopmental condi-
tions was a significant “pull factor” for schools and parents. It was also 
notable that the only children actively opted into the study because 
of parent concerns (and no other risk factor) were from the school in 
the most affluent setting (School 2). Thus, motivations to take part may 
differ depending on socioeconomic status. We would conclude that 
further research would be needed into how to incentivize parents of 
children with apparently typical development to take part.
CONCLUSIONS
This is the first study in the UK to directly assess FASD in a sys-
tematically ascertained sample of children. It found FASD in 1.8% 
(1.0%- 3.4%) of the population studied, or 3.6% (2.1%, 6.3%) when 
possible cases were also included. Due to the small sampling frame 
of schools included and limitations of baseline information obtained 
on contacted families, we can only conclude this represents local 
prevalence data in typical mainstream schools rather than being able 
confidently to infer a “population prevalence” of FASD. There are 
uncertainties too about this prevalence found, since half the children 
screened positive were lost to full ascertainment, and case identi-
fication may have been higher if all cases had been seen. Further 
research is needed to identify how to improve participation and ac-
curacy of PAE in European populations.
It was already suspected from modeling and screening studies 
that FASD is highly prevalent in the UK (Lange et al., 2017; McQuire 
et al., 2019). Confirmation that this is the case in a sample of schools 
should be used to increase the awareness of FASD, and invest in diag-
nostic services, treatment, and support for those affected by FASD.
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